Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sana BiotechnologySANA -1.66%32 3-Year EBITDA Growth Rate is 17.60% as of Jun. 2026, which is 58% above its 10-year median of 11.15. GuruFocus rates SANA with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 1,127 Biotechnology companies, Sana Biotechnology ranks better than 53.24% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 17.60% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 14.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 8 years, the highest 3-Year average EBITDA Per Share Growth Rate of Sana Biotechnology was 19.00% per year. The lowest was -8.40% per year. And the median was 11.15% per year.
Sana Biotechnology (NAS:SANA) 3-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Sana Biotechnology 3-Year EBITDA Growth Rate Related Terms
SANA vs APMD, ODTX, CRVS: 3-Year EBITDA Growth Rate Comparison
For the Biotechnology subindustry, Sana Biotechnology's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sana Biotechnology 3-Year EBITDA Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sana Biotechnology's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Sana Biotechnology's 3-Year EBITDA Growth Rate falls into.
Sana Biotechnology 3-Year EBITDA Growth Rate Calculation
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 17.60% mean?
Sana Biotechnology (SANA) has a 3-Year EBITDA Growth Rate of 17.60% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Sana Biotechnology and its competitors. This is 58% above median its historical median of 11.15. According to the industry distribution chart, Sana Biotechnology ranks #527 out of 1127 companies in the Biotechnology industry, placing it in the top 46.8%.
Is Sana Biotechnology's 3-Year EBITDA Growth Rate too high?
Sana Biotechnology's current 3-Year EBITDA Growth Rate of 17.60% is 58% above median its 10-year median of 11.15. The Biotechnology industry median 3-Year EBITDA Growth Rate is 14.60. Sana Biotechnology's value of 17.60% is 20.5% above this industry median. Based on the distribution chart, Sana Biotechnology ranks #527 out of 1127 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Sana Biotechnology has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Sana Biotechnology's 3-Year EBITDA Growth Rate compare to APMD and ODTX?
According to the Biotechnology industry distribution chart, Sana Biotechnology ranks #527 out of 1127 companies for 3-Year EBITDA Growth Rate. This puts Sana Biotechnology in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 14.60. Sana Biotechnology's value of 17.60% is 20.5% above this benchmark. While the company's 10-year median is 11.15 vs. the industry median of 14.60, Sana Biotechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Biotechnology company?
The median 3-Year EBITDA Growth Rate among Biotechnology companies is 14.60, based on 1,127 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sana Biotechnology's current 3-Year EBITDA Growth Rate of 17.60% is 20.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Sana Biotechnology and its competitors. For the Biotechnology industry, the median 3-Year EBITDA Growth Rate is 14.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sana Biotechnology's current 3-Year EBITDA Growth Rate is 17.60%, which is 58% above median its own 10-year median of 11.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sana Biotechnology stock overvalued right now?
Sana Biotechnology (SANA) has a current 3-Year EBITDA Growth Rate of 17.60%. The current 3-Year EBITDA Growth Rate is 17.60%, which is 58% above median its 10-year median of 11.15 and 20.5% above the Biotechnology industry median of 14.60. Sana Biotechnology's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Sana Biotechnology (SANA), the current 3-Year EBITDA Growth Rate is 17.60% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.
32GF Score
Get the complete analysis for SANA
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SANA has been successfully added to your 
